Clinical Trial

A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main objectives of this trial are: To assess the mass balance (total recovery of \[14C\]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.
Trial Details
NCT Number NCT07708493
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 8 participants
Start Date 2026-07-29
Primary Completion 2026-10-14 (estimated)
Study Completion 2026-10-14 (estimated)
Updated on ClinicalTrials.gov 2026-07-16